Skip to main content
. 2021 Mar 5:fdab055. doi: 10.1093/pubmed/fdab055

Table 2.

Main outcomes: disease severity, respiratory support and death among hospitalized patients

Hospital first (n = 618) Home to hospital (n = 128) Hotel to hospital (n = 14) All hospitalized patients (n = 760)
Disease severity no. (%)
Mild 444 (71.8) 95 (74.2) 11 (78.5) 550 (72.4)
Moderate 81 (13.1) 14 (10.9) 3 (21.5) 98 (12.9)
Severe 83 (13.4) 12 (9.3) 0 95 (12.5)
Missing data 10 (1.6) 7 (5.4) 0 17 (2.2)
Respiratory supportno. (%)
None 435 (70.4) 96 (75) 11 (78.6) 542 (71.3)
Oxygen Support 98 (15.8) 17 (13.3) 2 (14.3) 117 (15.4)
High-flow Oxygen 6 (1) 1 (0.7) 1 (7.1) 8 (1)
Mechanical Ventilation 69 (11.2) 10 (7.8) 0 79 (10.4)
Missing data 10 (1.6) 4 (3.2) 0 14 (1.8)
Deathno. (%)
51 (8.2) 4 (3) 55 (7.2)

Disease severity according to Israeli MoH criteria that were in force at the time of hospitalization:2 • Mild disease: Upper respiratory tract infection or pneumonia which does not comply with the definition of severe pneumonia.• Moderate disease: Pneumonia with one of the following: Respiratory rate of more than 30 per minute, respiratory distress, oxygen saturation less than 90% in room air.• Severe disease: Respiratory failure/acute respiratory distress syndrome, sepsis or shock.